Explore 25T7-NBOMe | PiHKAL · info

Exploring 25T7-NBOMe. To explore a different substance…

Names

25T7-NBOMe
N-(2-Methoxybenzyl)-4-propylthio-2,5-dimethoxyphenethylamine
2C-T-7-NBOMe

IUPAC names

2-[2,5-Dimethoxy-4-(propylsulfanyl)phenyl]-N-[(2-methoxyphenyl)methyl]ethan-1-amine
2-[2,5-Dimethoxy-4-(propylsulfanyl)phenyl]-N-(2-methoxybenzyl)ethan-1-amine

ID 1251 · Formula C₂₁H₂₉NO₃S · Molecular weight 375.525

InChI InChI=1S/C21H29NO3S/c1-5-12-26-21-14-19(24-3)16(13-20(21)25-4)10-11-22-15-17-8-6-7-9-18(17)23-2/h6-9,13-14,22H,5,10-12,15H2,1-4H3

InChI Key CPVMNHOHOSNFOP-UHFFFAOYSA-N This stereoisomer Any stereoisomer

SMILES CCCSc1cc(OC)c(cc1OC)CCNCc1ccccc1OC

PubChem 125181253
Wikidata Q110442950
Wikipedia, see 25-NB
Project Response 2C-T-7-NBOMe (1336-16)

Hansen, M. Design and synthesis of selective serotonin receptor agonists for positron emission tomography imaging of the brain Ph. D. Thesis, University of Copenhagen, 16 Dec 2012. 7.9 MB. #2.37 NMR

Casale, JF; Hays, PA. Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) derivatives and differentiation from their 3- and 4-methoxybenzyl analogues—Part I Microgram J., 1 Jan 2012, 9 (2), 84–109. 4.6 MB. #31: 25T7-NB2OMe GC,MS,IR

Leth-Petersen, S; Bundgaard, C; Hansen, M; Carnerup, MA; Kehler, J; Kristensen, JL. Correlating the metabolic stability of psychedelic 5-HT_2A agonists with anecdotal reports of human oral bioavailability Neurochem. Res., 12 Feb 2014, 39 (10), 2018-2023. 625 kB. https://doi.org/10.1007/s11064-014-1253-y #6b

Hays, PA; Casale, JF. Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) derivatives and differentiation from their 3-and 4-methoxybenzyl analogues - Part II Microgram J., 1 Jan 2014, 11 (1–4), 3–22. 8.1 MB. #31: 25T7-NB2OMe NMR

Rickli, A; Luethi, D; Reinisch, J; Buchy, D; Hoener, MC; Liechti, ME. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs) Neuropharmacology, 1 Dec 2015, 99, 546–553. 625 kB. https://doi.org/10.1016/j.neuropharm.2015.08.034 #25T7-NBOMe

Hansen, M; Phonekeo, K; Paine, JS; Leth-Petersen, S; Begtrup, M; Bräuner-Osborne, H; Kristensen, JL. Synthesis and structure–activity relationships of N-benzyl phenethylamines as 5-HT_2A/2C agonists ACS Chem. Neurosci., 19 Mar 2014, 5 (3), 243-249. 21.5 MB. https://doi.org/10.1021/cn400216u #12a NMR

Adamowicz, P; Zuba, D. Discrimination among designer drug isomers by chromatographic and spectrometric methods In Chromatographic Techniques in the Forensic Analysis of Designer Drugs; Kowalska, T; Sajewicz, M; Sherma, J, Eds., CRC Press, Taylor & Francis Group, 1 Jan 2018; pp 211–232. 1.1 MB. LC,MS,IR,UV

Grumann, C; Auwärter, V. Separation of positional isomers of nine 2-phenethylamine-derived designer drugs by liquid chromatography-tandem mass spectrometry Drug Test. Anal., 1 Jul 2018, 10 (7), 1184–1191. 861 kB. https://doi.org/10.1002/dta.2371 #25T7-NBOMe LC,MS

Luethi, D; Liechti, ME. Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics Int. J. Neuropsychoph., 1 Oct 2018, 21 (10), 926–931. 254 kB. https://doi.org/10.1093/ijnp/pyy047 #S2 Phenethylamines 25T7-NBOMe

25T4-NBOMe · 2C-T-4-NBOMe · N-(2-Methoxybenzyl)-4-isopropylthio-2,5-dimethoxyphenethylamine

25T4-NB3OMe · N-(3-Methoxybenzyl)-4-isopropylthio-2,5-dimethoxyphenethylamine

25T4-NB4OMe · N-(4-Methoxybenzyl)-4-isopropylthio-2,5-dimethoxyphenethylamine

25T7-NB3OMe · N-(3-Methoxybenzyl)-4-propylthio-2,5-dimethoxyphenethylamine

25T7-NB4OMe · N-(4-Methoxybenzyl)-4-propylthio-2,5-dimethoxyphenethylamine

13450

7 Dec 2019 · · Isomer Design